Fig. 1

(A) Seroprevalence of particular anti-SARS-CoV-2 IgG, IgM, and IgA antibodies in the children with serological evidence of viral exposure. (B) Concentration (median and interquartile range) of particular anti-SARS-CoV-2 antibodies in seropositive children.